title: Moving forward with evidence and controversies: the challenges of MDR-TB.
authors.forename: Chen-Yuan
authors.initials: CY
authors.lastname: Chiang
authors.forename: Armand
authors.initials: A
authors.lastname: Van Deun
authors.forename: Jose A
authors.initials: JA
authors.lastname: Caminero
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery
chemical_list: D000904:Antibiotics, Antitubercular; D007538:Isoniazid; D012293:Rifampin